Employees: 01 (2023.0)Legal category: 5485Size: PMECreation date: 2018-04-11 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PREMESQUES (59840), Nord
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE PREMESQUES : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE PREMESQUES is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PREMESQUES (59840),
this company of category PME
shows in 2022 a revenue of 1.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE PREMESQUES (SIREN 839403938)
Indicator
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
1 112 460 €
N/C
N/C
N/C
Net income
52 438 €
75 569 €
92 754 €
75 122 €
40 047 €
5 954 €
EBITDA
N/C
N/C
124 172 €
N/C
N/C
N/C
Net margin
N/C
N/C
8.3%
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE DE PREMESQUES generates positive net income of 52 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2024: 6 k€ -> 52 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
52 438 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 93%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
93.157%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
43.634%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE PREMESQUES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Debt ratio
990.258
545.258
287.189
177.564
120.179
93.157
Financial autonomy
7.731
13.311
22.459
30.695
37.401
43.634
Repayment capacity
None
None
None
5.29
None
None
Cash flow / Revenue
None%
None%
None%
7.963%
None%
None%
Sector positioning
Debt ratio
93.162024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average-15 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE DE PREME... (93.16) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
43.63%2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average+15 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DE PREME... (43.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
5.29 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL PHARMACIE DE PREME... (5.29) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 296.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
296.457
Liquidity indicators evolution SELARL PHARMACIE DE PREMESQUES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
Liquidity ratio
200.942
228.622
274.233
295.923
265.801
296.457
Interest coverage
None
None
None
1.935
None
None
Sector positioning
Liquidity ratio
296.462024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Excellent
In 2024, the liquidity ratio of SELARL PHARMACIE DE PREME... (296.46) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.94x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of SELARL PHARMACIE DE PREME... (1.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 161 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 773 days. Excellent situation: suppliers finance 612 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
161 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
773 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE PREMESQUES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
111 502 €
0 €
0 €
Inventory turnover (days)
0
0
0
35
0
0
Customer payment term (days)
165
168
138
7
170
161
Supplier payment term (days)
877
639
596
37
838
773
Positioning of SELARL PHARMACIE DE PREMESQUES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DE PREMESQUES is estimated at
732 073 €
(range 509 804€ - 1 095 223€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
509k€732k€1095k€
732 073 €Range: 509 804€ - 1 095 223€
NAF 5 année 2024
Valuation method used
Net Income Multiple
52 438 €
×
14.0x
=732 073 €
Range: 509 804€ - 1 095 223€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE PREMESQUES with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE PREMESQUES
What is the revenue of SELARL PHARMACIE DE PREMESQUES ?
The revenue of SELARL PHARMACIE DE PREMESQUES in 2022 is 1.1 M€.
Is SELARL PHARMACIE DE PREMESQUES profitable?
Yes, SELARL PHARMACIE DE PREMESQUES generated a net profit of 52 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DE PREMESQUES ?
The headquarters of SELARL PHARMACIE DE PREMESQUES is located in PREMESQUES (59840), in the department Nord.
Where to find the tax return of SELARL PHARMACIE DE PREMESQUES ?
The tax return of SELARL PHARMACIE DE PREMESQUES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE PREMESQUES operate?
SELARL PHARMACIE DE PREMESQUES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart